МЕХАНИЗМ РАЗВИТИЯ КОГНИТИВНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ
Аннотация
Актуальность изучения когнитивных нарушений у пациентов с сахарным диабетом (СД) для практикующих врачей обусловлена тем, что, согласно сведениям ВОЗ, в 2022 г. в мире насчитывалось 537 млн пациентов с СД, по неутешительным прогнозам, к 2045 г. их количество возрастет до 784 млн человек. По эпидемиологическим данным, в настоящее время в мире около 40 млн человек страдают деменцией и когнитивной дисфункцией. СД относится к наиболее распространенной группе заболеваний, вызывающих физиологические и патологические изменения в сосудах головного мозга, что приводит к развитию когнитивных нарушений. Данная тема недостаточно изучена. В современной литературе имеются противоречивые сведения по этому вопросу, что вызывает необходимость провести анализ факторов риска и особенностей когнитивных дисфункций при СД.
Литература
Bai W, Chen P, Cai H, Zhang Q, Su Z, Cheung T, Jackson T, Sha S, Xiang YT. Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age Ageing. 2022;51(8):afac173. https://doi.org/10.1093/ageing/afac173.
Lezak MD. Neuropsychology assessment. 3th еd. New York: Oxford University Press; 1995. 1026 p.
Zaharov VV. Kognitivnye narushenija v nevrologicheskoj praktike. Trudnyj pacient [Difficult patient]. 2005;3(5):4-9. edn: OCSFKZ. (Russian).
Nuckols CC. The Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Philadelphia: American Psychiatric Association; 2013. 947 р.
Antonova KV, Tanashyan MM. Cognitive impairment among patients with diabetes. Role of cobalamin. Jendokrinologija. Novosti. Mnenija. Obuchenie [Endocrinology. News. Opinions. Training]. 2022;11(4(41)):60-69. https://doi.org/10.33029/2304-9529-2022-11-4-60-69. https://www.elibrary.ru/zqsfty. (Russian).
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63-75.e2. https://doi.org/10.1016/j.jalz.2012.11.007.
Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimers and vascular types. Biomed Res Int. 2014;2014:908915. https://doi.org/10.1155/2014/908915.
Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, Beiser A, Borenstein AR, Crane PK, Haan M, Hassing LB, Hayden KM, Kiyohara Y, Larson EB, Li CY, Ninomiya T, Ohara T, Peters R, Russ TC, Seshadri S, Strand BH, Walker R, Xu W, Huxley RR. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39(2):300-307. https://doi.org/10.2337/dc15-1588.
Rdzak GM, Abdelghany O. Does insulin therapy for type 1 diabetes mellitus protect against Alzheimer's disease? Pharmacotherapy. 2014;34(12):1317-1323. https://doi.org/10.1002/phar.1494.
Tanashyan ММ, Lagoda OV, Antonova KV, Raskurazhev AA, Chatskaya AV. Cognitive dysfunction in patients with cerebrovascular disease and diabetes. Klinicheskaja farmakologija i terapija. 2017;26(5):25-30. edn: ZVLJKX. (Russian).
Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB. Glucose levels and risk of dementia. N Engl J Med. 2013;369(6):540-548. https://doi.org/10.1056/NEJMoa1215740.
Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S, Kiyohara Y. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology. 2011;77(12):1126-1134. https://doi.org/10.1212/WNL.0b013e31822f0435.
Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care. 2007;30(10):2655-2660. https://doi.org/10.2337/dc06-1190.
Tanashjan MM, Lagoda OV, Antonova KV. Cerebrovaskuljarnaja patologija i metabolicheskij sindrom. Moscow: AST 345; 2019. 376 p. https://doi.org/10.33901/978-5-6041430-2-5-2019-1-370. https://www.elibrary.ru/sbmylf. (Russian).
Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and Cognitive Impairment. Curr Diab Rep. 2016;16(9):87. https://doi.org/10.1007/s11892-016-0775-x.
Luneva IE, Suponeva NA. Cognitive disorders in people with diabetes mellitus. Jeffektivnaja farmakoterapija [Effective Pharmacotherapy]. 2022;18(10):38-44. https://doi.org/10.33978/2307-3586-2022-18-10-38-44. https://www.elibrary.ru/sovhvq. (Russian).
Gaspar JM, Baptista FI, Macedo MP, Ambrósio AF. Inside the diabetic brain: role of different players involved in cognitive decline. ACS Chem Neurosci. 2016;7(2):131-142. https://doi.org/10.1021/acschemneuro.5b00240.
Choi J, Chandrasekaran K, Demarest TG, Kristian T, Xu S, Vijaykumar K, Dsouza KG, Qi NR, Yarowsky PJ, Gallipoli R, Koch LG, Fiskum GM, Britton SL, Russell JW. Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity. Ann Clin Transl Neurol. 2014;1(8):589-604. https://doi.org/10.1002/acn3.86.
Antonova KV. Cerebrovaskuljarnaja patologija pri saharnom diabete 2 tipa: patogeneticheskie faktory i varianty techenija [dissertation]. Moscow (Russia): Research Center of Neurology; 2020. 278 l. edn: ACTXHI. (Russian).
Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, Rowe Ch, Watters DA. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 2013;36(10):2981-2987. https://doi.org/10.2337/dc13-0229.
Baroni L, Bonetto Ch, Rizzo G, Bertola C, Caberlotto L, Bazzerla G. Association between cognitive impairment and vitamin B12, folate, and homocysteine status in elderly adults: a retrospective study. J Alzheimers Dis. 2019;70(2):443-453. https://doi.org/10.3233/JAD-190249.
Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356(18):1842-1852.https://doi.org/10.1056/NEJMoa066397.
Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004;63(4):658-663. https://doi.org/10.1212/01.wnl.0000134666.64593.ba.
Van den Berg E, Reijmer YD, De Bresser J, Kessels RPC, Kappelle LJ, Biessels GJ. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58-65. https://doi.org/10.1007/s00125-009-1571-9.
Ostroumova OD, Surkova EV, Chih EV, Rebrova EV, Borisov MS. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Saharnyj diabet [Diabetes mellitus]. 2018;21(4):307-318. https://doi.org/10.14341/DM9660. https://www.elibrary.ru/vjntyi. (Russian).
Mokhort TV. Cognitive function and diabetes mellitus: what should know the clinician? Meditsinskie novosti [Medical news]. 2018;(10(289)):13-20. edn: YOFIUH. (Russian).
Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Flöel A. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology. 2013;81(20):1746-1752. https://doi.org/10.1212/01.wnl.0000435561.00234.ee.
Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565-1572. https://doi.org/10.1001/jama.2009.460.
Vasenina YeYe, Levin OS. Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. Jeffektivnaja farmakoterapija. Jendokrinologija [Effective pharmacotherapy. Endocrinology]. 2016;29(3):40-47. edn: XSIIUH. (Russian).
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE. Demonstrated brain insulin resistance in Alzheimers disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122(4):1316-1338. https://doi.org/10.1172/JCI59903.
